Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration
dc.citation.articleNumber | 25 | en_US |
dc.citation.journalTitle | Journal of Experimental Orthopaedics | en_US |
dc.citation.volumeNumber | 3 | en_US |
dc.contributor.author | Chiu, Yu-Chieh | en_US |
dc.contributor.author | Fong, Eliza L.S. | en_US |
dc.contributor.author | Grindel, Brian J. | en_US |
dc.contributor.author | Kasper, Fred K. | en_US |
dc.contributor.author | Harrington, Daniel Anton | en_US |
dc.contributor.author | Farach-Carson, Mary C. | en_US |
dc.date.accessioned | 2017-03-07T17:07:15Z | en_US |
dc.date.available | 2017-03-07T17:07:15Z | en_US |
dc.date.issued | 2016 | en_US |
dc.description.abstract | Background: Biomaterial scaffolds that deliver growth factors such as recombinant human bone morphogenetic proteins-2 (rhBMP-2) have improved clinical bone tissue engineering by enhancing bone tissue regeneration. This approach could be further improved if the controlled delivery of bioactive rhBMP-2 were sustained throughout the duration of osteogenesis from fibrous scaffolds that provide control over dose and bioactivity of rhBMP-2. In nature, heparan sulfate attached to core proteoglycans serves as the co-receptor that delivers growth factors to support tissue morphogenesis. Methods: To mimic this behavior, we conjugated heparan sulfate decorated recombinant domain I of perlecan/HSPG2 onto an electrospun poly(ε-caprolactone) (PCL) scaffold, hypothesizing that the heparan sulfate chains will enhance rhBMP-2 loading onto the scaffold and preserve delivered rhBMP-2 bioactivity. Results: In this study, we demonstrated that covalently conjugated perlecan domain I increased loading capacity of rhBMP-2 onto PCL scaffolds when compared to control unconjugated scaffolds. Additionally, rhBMP-2 released from the modified scaffolds enhanced alkaline phosphatase activity in W20–17 mouse bone marrow stromal cells, indicating the preservation of rhBMP-2 bioactivity indicative of osteogenesis. Conclusions: We conclude that this platform provides a sophisticated and efficient approach to deliver bioactive rhBMP-2 for bone tissue regeneration applications. | en_US |
dc.identifier.citation | Chiu, Yu-Chieh, Fong, Eliza L.S., Grindel, Brian J., et al.. "Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration." <i>Journal of Experimental Orthopaedics,</i> 3, (2016) Springer Nature: http://dx.doi.org/10.1186/s40634-016-0057-1. | en_US |
dc.identifier.doi | http://dx.doi.org/10.1186/s40634-016-0057-1 | en_US |
dc.identifier.uri | https://hdl.handle.net/1911/94022 | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Springer Nature | en_US |
dc.rights | This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. | en_US |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | en_US |
dc.subject.keyword | Heparan sulfate | en_US |
dc.subject.keyword | Poly(ε-caprolactone) | en_US |
dc.subject.keyword | Bone morphogenetic protein | en_US |
dc.subject.keyword | Alkaline phosphatase | en_US |
dc.subject.keyword | Perlecan/HSPG2 | en_US |
dc.subject.keyword | Bone regeneration | en_US |
dc.title | Sustained delivery of recombinant human bone morphogenetic protein-2 from perlecan domain I - functionalized electrospun poly (ε-caprolactone) scaffolds for bone regeneration | en_US |
dc.type | Journal article | en_US |
dc.type.dcmi | Text | en_US |
dc.type.publication | publisher version | en_US |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- SustainedDelivery.pdf
- Size:
- 801.01 KB
- Format:
- Adobe Portable Document Format
- Description: